Cargando…

Impact of a treatment escalation/limitation plan on non-beneficial interventions and harms in patients during their last admission before in-hospital death, using the Structured Judgment Review Method

OBJECTIVES: To assess the effect of using a treatment escalation/limitation plan (TELP) on the frequency of harms in 300 patients who died following admission to hospital. DESIGN: A retrospective case note review of 300 unselected, consecutive deaths comprising: (1) patients with a TELP in addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Lightbody, Calvin J, Campbell, Jonathan N, Herbison, G Peter, Osborne, Heather K, Radley, Alice, Taylor, D Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252685/
https://www.ncbi.nlm.nih.gov/pubmed/30385448
http://dx.doi.org/10.1136/bmjopen-2018-024264
_version_ 1783373320582856704
author Lightbody, Calvin J
Campbell, Jonathan N
Herbison, G Peter
Osborne, Heather K
Radley, Alice
Taylor, D Robin
author_facet Lightbody, Calvin J
Campbell, Jonathan N
Herbison, G Peter
Osborne, Heather K
Radley, Alice
Taylor, D Robin
author_sort Lightbody, Calvin J
collection PubMed
description OBJECTIVES: To assess the effect of using a treatment escalation/limitation plan (TELP) on the frequency of harms in 300 patients who died following admission to hospital. DESIGN: A retrospective case note review of 300 unselected, consecutive deaths comprising: (1) patients with a TELP in addition to a do-not-attempt cardiopulmonary resuscitation order (DNACPR); (2) those with DNACPR only; and (3) those with neither. Patient deaths were classified retrospectively as ‘expected’ or ‘unexpected’ using the Gold Standard Framework Prognostic Indicator Guidance. SETTING: Medical, surgical and intensive care units of a district general hospital. OUTCOMES: The primary outcome was the between-group difference in rates of harms, non-beneficial interventions (NBIs) and clinical ‘problems’ identified using the Structured Judgement Review Method. RESULTS: 289 case records were evaluable. 155 had a TELP and DNACPR (54%); 113 had DNACPR only (39%); 21 had neither (7%). 247 deaths (86%) were ‘expected’. Among patients with ‘expected’ deaths and using the TELP/DNACPR as controls (incidence rate ratio (IRR)=1.00), the IRRs were: for harms, 2.99 (DNACPR only) and 4.00 (neither TELP nor DNACPR) (p<0.001 for both); for NBIs, the corresponding IRRs were 2.23 (DNACPR only) and 2.20 (neither) (p<0.001 and p<0.005, respectively); for ‘problems’, 2.30 (DNACPR only) and 2.76 (neither) (p<0.001 for both). The rates of harms, NBIs and ‘problems’ were significantly lower in the group with a TELP/DNACPR compared with ‘DNACPR only’ and ‘neither’: harms (per 1000 bed days) 17.1, 76.9 (p<0.001) and 197.8 (p<0.001) respectively; NBIs: 27.4, 92.1 (p<0.001) and 172.4 (p<0.001); and ‘problems’: 42.3, 146.2 (p<0.01) and 333.3 (p<0.001). CONCLUSIONS: The use of a TELP was associated with a significant reduction in harms, NBIs and ‘problems’ in patients admitted acutely and who subsequently died, especially if they were likely to be in the last year of life.
format Online
Article
Text
id pubmed-6252685
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-62526852018-12-11 Impact of a treatment escalation/limitation plan on non-beneficial interventions and harms in patients during their last admission before in-hospital death, using the Structured Judgment Review Method Lightbody, Calvin J Campbell, Jonathan N Herbison, G Peter Osborne, Heather K Radley, Alice Taylor, D Robin BMJ Open Patient-Centred Medicine OBJECTIVES: To assess the effect of using a treatment escalation/limitation plan (TELP) on the frequency of harms in 300 patients who died following admission to hospital. DESIGN: A retrospective case note review of 300 unselected, consecutive deaths comprising: (1) patients with a TELP in addition to a do-not-attempt cardiopulmonary resuscitation order (DNACPR); (2) those with DNACPR only; and (3) those with neither. Patient deaths were classified retrospectively as ‘expected’ or ‘unexpected’ using the Gold Standard Framework Prognostic Indicator Guidance. SETTING: Medical, surgical and intensive care units of a district general hospital. OUTCOMES: The primary outcome was the between-group difference in rates of harms, non-beneficial interventions (NBIs) and clinical ‘problems’ identified using the Structured Judgement Review Method. RESULTS: 289 case records were evaluable. 155 had a TELP and DNACPR (54%); 113 had DNACPR only (39%); 21 had neither (7%). 247 deaths (86%) were ‘expected’. Among patients with ‘expected’ deaths and using the TELP/DNACPR as controls (incidence rate ratio (IRR)=1.00), the IRRs were: for harms, 2.99 (DNACPR only) and 4.00 (neither TELP nor DNACPR) (p<0.001 for both); for NBIs, the corresponding IRRs were 2.23 (DNACPR only) and 2.20 (neither) (p<0.001 and p<0.005, respectively); for ‘problems’, 2.30 (DNACPR only) and 2.76 (neither) (p<0.001 for both). The rates of harms, NBIs and ‘problems’ were significantly lower in the group with a TELP/DNACPR compared with ‘DNACPR only’ and ‘neither’: harms (per 1000 bed days) 17.1, 76.9 (p<0.001) and 197.8 (p<0.001) respectively; NBIs: 27.4, 92.1 (p<0.001) and 172.4 (p<0.001); and ‘problems’: 42.3, 146.2 (p<0.01) and 333.3 (p<0.001). CONCLUSIONS: The use of a TELP was associated with a significant reduction in harms, NBIs and ‘problems’ in patients admitted acutely and who subsequently died, especially if they were likely to be in the last year of life. BMJ Publishing Group 2018-10-31 /pmc/articles/PMC6252685/ /pubmed/30385448 http://dx.doi.org/10.1136/bmjopen-2018-024264 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Patient-Centred Medicine
Lightbody, Calvin J
Campbell, Jonathan N
Herbison, G Peter
Osborne, Heather K
Radley, Alice
Taylor, D Robin
Impact of a treatment escalation/limitation plan on non-beneficial interventions and harms in patients during their last admission before in-hospital death, using the Structured Judgment Review Method
title Impact of a treatment escalation/limitation plan on non-beneficial interventions and harms in patients during their last admission before in-hospital death, using the Structured Judgment Review Method
title_full Impact of a treatment escalation/limitation plan on non-beneficial interventions and harms in patients during their last admission before in-hospital death, using the Structured Judgment Review Method
title_fullStr Impact of a treatment escalation/limitation plan on non-beneficial interventions and harms in patients during their last admission before in-hospital death, using the Structured Judgment Review Method
title_full_unstemmed Impact of a treatment escalation/limitation plan on non-beneficial interventions and harms in patients during their last admission before in-hospital death, using the Structured Judgment Review Method
title_short Impact of a treatment escalation/limitation plan on non-beneficial interventions and harms in patients during their last admission before in-hospital death, using the Structured Judgment Review Method
title_sort impact of a treatment escalation/limitation plan on non-beneficial interventions and harms in patients during their last admission before in-hospital death, using the structured judgment review method
topic Patient-Centred Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252685/
https://www.ncbi.nlm.nih.gov/pubmed/30385448
http://dx.doi.org/10.1136/bmjopen-2018-024264
work_keys_str_mv AT lightbodycalvinj impactofatreatmentescalationlimitationplanonnonbeneficialinterventionsandharmsinpatientsduringtheirlastadmissionbeforeinhospitaldeathusingthestructuredjudgmentreviewmethod
AT campbelljonathann impactofatreatmentescalationlimitationplanonnonbeneficialinterventionsandharmsinpatientsduringtheirlastadmissionbeforeinhospitaldeathusingthestructuredjudgmentreviewmethod
AT herbisongpeter impactofatreatmentescalationlimitationplanonnonbeneficialinterventionsandharmsinpatientsduringtheirlastadmissionbeforeinhospitaldeathusingthestructuredjudgmentreviewmethod
AT osborneheatherk impactofatreatmentescalationlimitationplanonnonbeneficialinterventionsandharmsinpatientsduringtheirlastadmissionbeforeinhospitaldeathusingthestructuredjudgmentreviewmethod
AT radleyalice impactofatreatmentescalationlimitationplanonnonbeneficialinterventionsandharmsinpatientsduringtheirlastadmissionbeforeinhospitaldeathusingthestructuredjudgmentreviewmethod
AT taylordrobin impactofatreatmentescalationlimitationplanonnonbeneficialinterventionsandharmsinpatientsduringtheirlastadmissionbeforeinhospitaldeathusingthestructuredjudgmentreviewmethod